Related Experiment Video

Updated: Jul 30, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

[Clinico-morphological comparison in children with infectious endocarditis]

N A Tiurin, O P Alekseeva, Iu N Iaroshinskiĭ

    Pediatriia
    |January 1, 1991
    PubMed

    Insights

    Diagnosing infectious endocarditis (IE) in children is challenging, often delaying treatment. This study highlights IE

    Area of Science:

    • Pediatric Cardiology
    • Infectious Diseases
    • Pathology

    Background:

    • Infectious endocarditis (IE) is a serious heart infection.
    • Pediatric IE cases present unique clinical and morphological challenges.
    • Understanding IE's impact on young patients is crucial for timely intervention.

    Purpose of the Study:

    • To analyze the clinical and morphological features of infectious endocarditis in children.
    • To identify diagnostic difficulties and their impact on treatment initiation.
    • To investigate associated cardiac pathologies and causes of mortality in pediatric IE.

    Main Methods:

    • Retrospective analysis of 21 pediatric patients with infectious endocarditis.
    • Examination of clinical data, including age, underlying conditions, and diagnosis.
    • Morphological examination of cardiac tissues from autopsy (19 cases) and surgical (2 cases) specimens.

    Main Results:

    • IE was diagnosed in children aged 2-15 years, often associated with congenital heart disease (15/21).
    • Early diagnosis of IE proved difficult, leading to delayed antibacterial therapy.
    • Focal myocarditis and postmyocarditic cardiosclerosis were common, contributing to refractory heart failure.

    Conclusions:

    • Difficulties in early IE diagnosis in children can delay critical antibacterial treatment.
    • Associated myocarditis and cardiosclerosis contribute significantly to heart failure in pediatric IE.
    • Heart failure and thromboembolism remain the primary causes of mortality in children with IE.

    More Related Videos

    En Face Endocardial Cushion Preparation for Planar Morphogenesis Analysis in Mouse Embryos08:57

    En Face Endocardial Cushion Preparation for Planar Morphogenesis Analysis in Mouse Embryos

    Published on: July 27, 2022

    Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy06:38

    Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

    Published on: September 26, 2025

    Related Concept Videos

    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

    Mitral Stenosis II: Clinical features and Diagnostic Tests

    Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
    Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

    Aortic Regurgitation II: Clinical Features and Diagnostic Tests

    Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Myocarditis II: Clinical Features and Diagnostic Tests01:27

    Myocarditis II: Clinical Features and Diagnostic Tests

    Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...